Merck KGaA
MKGAF
$163.71
-$4.70-2.79%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 5.79% | 5.69% | 4.22% | 3.43% | 2.26% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 5.79% | 5.69% | 4.22% | 3.43% | 2.26% |
| Cost of Revenue | 4.76% | 6.90% | 5.04% | 3.21% | 1.63% |
| Gross Profit | 6.52% | 4.86% | 3.65% | 3.58% | 2.72% |
| SG&A Expenses | 10.09% | 9.73% | 7.14% | 7.21% | 4.79% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -165.40% | -139.73% | -78.88% | -123.98% | -81.04% |
| Total Operating Expenses | 8.95% | 7.08% | 5.22% | -1.06% | -2.04% |
| Operating Income | -6.41% | 0.12% | 0.18% | 24.59% | 23.20% |
| Income Before Tax | -11.36% | -3.71% | -2.73% | 12.73% | 12.03% |
| Income Tax Expenses | -9.77% | -5.63% | -4.25% | 16.24% | 21.64% |
| Earnings from Continuing Operations | -11.78% | -3.19% | -2.32% | 11.86% | 9.73% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -29.64% | -115.01% | 25.45% | 46.57% | -66.16% |
| Net Income | -11.95% | -3.47% | -2.24% | 12.04% | 9.58% |
| EBIT | -6.41% | 0.12% | 0.18% | 24.59% | 23.20% |
| EBITDA | 3.40% | 7.49% | 6.04% | 12.84% | 11.28% |
| EPS Basic | -11.90% | -3.51% | -2.44% | 11.82% | 9.41% |
| Normalized Basic EPS | -7.34% | -0.99% | 0.07% | 19.96% | 19.23% |
| EPS Diluted | -11.90% | -3.51% | -2.44% | 11.91% | 9.50% |
| Normalized Diluted EPS | -7.34% | -0.99% | 0.07% | 19.96% | 19.23% |
| Average Basic Shares Outstanding | -0.09% | 0.04% | 0.19% | 0.19% | 0.15% |
| Average Diluted Shares Outstanding | -0.09% | 0.04% | 0.19% | 0.19% | 0.15% |
| Dividend Per Share | 9.21% | 9.21% | 9.21% | -0.99% | -0.99% |
| Payout Ratio | 0.14% | 0.08% | 0.08% | -0.05% | -0.03% |